找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drugs between Research and Regulations; Proceedings of the 5 C. Steichele (Medizinischer Direktor),U. Abshagen Conference proceedings 1985

[復制鏈接]
樓主: 無感覺
11#
發(fā)表于 2025-3-23 12:24:24 | 只看該作者
https://doi.org/10.1007/978-1-4842-4950-5sons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.
12#
發(fā)表于 2025-3-23 16:21:52 | 只看該作者
Installing Third-Party Libraries,linical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
13#
發(fā)表于 2025-3-23 19:48:03 | 只看該作者
Clinical guidelines — a help or a hindrance?cceed, now and again, in thwarting their deliberations and obscuring their aims. The issue of Guidelines for the Clinical Investigation of Drugs is a case in point. They are hailed by some and condemned by others and nine tenths of the problem is that the one party really has little idea what the other party is talking about.
14#
發(fā)表于 2025-3-23 23:51:22 | 只看該作者
15#
發(fā)表于 2025-3-24 03:04:13 | 只看該作者
Alternatives to clinical trials in post-marketing research on drug effectslinical trials, with special reference to drug evaluation after marketing (Phase IV). I shall deal with it from the vantage of a decade and a half of consultation work in this area, especially with the Drug Epidemiology Unit of Boston University School of Medicine.
16#
發(fā)表于 2025-3-24 07:28:05 | 只看該作者
Managing Device Drivers and PC ResourcesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
17#
發(fā)表于 2025-3-24 10:44:29 | 只看該作者
18#
發(fā)表于 2025-3-24 14:49:36 | 只看該作者
The organisation of long-term intervention and prevention studiesRisk: benefit decision making lies at the heart of modern therapeutics, and it is possible to distinguish between four categories of problem.
19#
發(fā)表于 2025-3-24 20:33:56 | 只看該作者
20#
發(fā)表于 2025-3-25 00:30:33 | 只看該作者
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-28 23:49
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
吉林省| 常德市| 吉首市| 会昌县| 通山县| 榆树市| 江陵县| 安仁县| 东乌| 佛学| 云龙县| 津南区| 洞口县| 乐清市| 磴口县| 定襄县| 平安县| 永福县| 金山区| 额尔古纳市| 方城县| 尚义县| 拉萨市| 白沙| 福安市| 密云县| 邵武市| 皮山县| 周口市| 满洲里市| 犍为县| 都兰县| 瓦房店市| 岳西县| 巧家县| 泸州市| 水城县| 墨竹工卡县| 临夏县| 彰化市| 黄大仙区|